ABOG OB/GYN Qualifying Exam flashcards
ABOG OB/GYN Qualifying Exam · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Preeclampsia severe features
- BP ≥160/110, platelets <100,000, AST/ALT >2× normal, creatinine >1.1 mg/dL, pulmonary edema, or new cerebral or visual symptoms; delivery is indicated at ≥34 weeks.
- Postpartum hemorrhage first-line
- Uterine atony is the most common cause; initial management is uterine massage and oxytocin, followed by methylergonovine (avoid in hypertension) and carboprost (avoid in asthma).
- Magnesium sulfate antidote
- Calcium gluconate 1 g IV is the antidote for magnesium toxicity; monitor deep tendon reflexes, respiratory rate, and urine output during infusion.
- Shoulder dystocia sequence
- McRoberts positioning and suprapubic pressure first, then internal rotation maneuvers, posterior arm delivery, and all-fours position; avoid fundal pressure.
- Gestational diabetes diagnosis
- Carpenter-Coustan 100-g OGTT thresholds are fasting 95, 1 h 180, 2 h 155, 3 h 140 mg/dL; two or more abnormal values confirm gestational diabetes.
- Group B strep prophylaxis
- Intrapartum penicillin G is first-line; cefazolin for non-anaphylactic penicillin allergy; clindamycin (with susceptibility) or vancomycin for anaphylaxis.
- RhD immune globulin timing
- Give 300 mcg at 28 weeks and within 72 hours postpartum for Rh-negative unsensitized patients; Kleihauer-Betke testing guides additional dosing for large fetomaternal hemorrhage.
- Antenatal corticosteroids
- Betamethasone 12 mg IM twice, 24 hours apart, between 24 and 34 weeks gestation reduces neonatal respiratory distress and other complications of prematurity.
- PALM-COEIN classification
- Structural causes are Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia; nonstructural causes are Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, and Not otherwise classified.
- Postmenopausal bleeding evaluation
- Endometrial stripe >4 mm on transvaginal ultrasound or persistent bleeding warrants endometrial sampling to exclude hyperplasia or carcinoma.
- Cervical cancer screening ages
- Begin cytology at age 21 every 3 years; co-testing every 5 years from age 30; stop at 65 with adequate prior negative screening.
- Ovarian torsion management
- Sudden unilateral pelvic pain with nausea suggests torsion; Doppler flow may be normal; treatment is laparoscopic detorsion with ovarian preservation.
- Ectopic pregnancy methotrexate
- Discriminatory hCG is 3,500 mIU/mL for transvaginal ultrasound; methotrexate is contraindicated with hepatic or renal disease, breastfeeding, or adnexal mass >3.5-4 cm.
- Endometrial cancer risk factors
- Obesity, nulliparity, unopposed estrogen, tamoxifen, and chronic anovulation increase risk; type I is estrogen-driven endometrioid carcinoma.
- Fibroid treatment options
- GnRH agonists shrink leiomyomas preoperatively; tranexamic acid and ulipristal manage bleeding; hysteroscopy is appropriate for submucosal fibroids.
- Endometriosis treatment goals
- Hormonal suppression (combined contraceptives, progestins, GnRH agonists) reduces pain but does not improve fertility; laparoscopy is diagnostic.
- Combined contraceptive contraindications
- Migraine with aura, smoking over age 35, hypertension, VTE history, and breast cancer are contraindications; progestin-only methods are often preferred.
- Emergency contraception efficacy
- Copper IUD is most effective and can be placed up to 5 days after unprotected intercourse; ulipristal and levonorgestrel efficacy decline with time and higher BMI.
- Osteoporosis screening
- DXA at age 65 for all women, or earlier with risk factors; FRAX guides treatment; bisphosphonates are first-line pharmacotherapy.
- Bacterial vaginosis criteria
- Amsel criteria: ≥3 of homogeneous discharge, clue cells, pH >4.5, positive whiff test; treat with metronidazole or clindamycin; partner treatment not indicated.
- Abnormal cervical cytology
- ASC-US with negative HPV returns to routine screening; ASC-US with positive HPV or LSIL warrants colposcopy; HSIL warrants colposcopy with excision.
- Hypertension in pregnancy treatment
- Chronic hypertension predates 20 weeks or persists postpartum; treat with labetalol, nifedipine, or methyldopa; ACE inhibitors and ARBs are teratogenic.
- Thyroid disease in pregnancy
- Levothyroxine requirements increase; TSH targets are trimester-specific, generally <2.5-3.0 mIU/L in the first trimester.
- Breast cancer high-risk screening
- BRCA1/2 carriers have markedly elevated lifetime risk; MRI screening in addition to mammography is recommended for high-risk patients, typically from age 30.
- PCOS diagnostic criteria
- Rotterdam criteria require ≥2 of oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovaries; letrozole is preferred for ovulation induction.
- Infertility workup
- Infertility is 12 months of unprotected intercourse (6 months if age ≥35); workup includes semen analysis, ovulation assessment, tubal patency, and ovarian reserve testing.
- Stress incontinence treatment
- Pelvic floor muscle training is first-line; midurethral sling or Burch colposuspension for surgical cases; pessaries are non-surgical options.
- Pelvic inflammatory disease
- Treat with ceftriaxone plus doxycycline plus metronidazole; tubo-ovarian abscess may require drainage.
- Cell-free DNA screening
- Best for trisomy 21, 18, and 13; it is a screening test, and diagnostic confirmation requires amniocentesis or chorionic villus sampling.
- Twin pregnancy surveillance
- Monoamniotic twins require close surveillance due to cord entanglement; TTTS occurs in monochorionic-diamniotic twins.
- High-risk endometrial cancer
- Grade 3, deep myometrial invasion, and LVSI may require lymph node assessment; carboplatin/paclitaxel is standard for advanced disease.
- Laparoscopic entry techniques
- Options include Veress needle and Hasson (open) technique; convert to laparotomy for uncontrolled bleeding or inability to proceed safely.